ES2051643A1 - Oral ubidecarenone formulations in the form of aqueous solutions - Google Patents
Oral ubidecarenone formulations in the form of aqueous solutionsInfo
- Publication number
- ES2051643A1 ES2051643A1 ES09202032A ES9202032A ES2051643A1 ES 2051643 A1 ES2051643 A1 ES 2051643A1 ES 09202032 A ES09202032 A ES 09202032A ES 9202032 A ES9202032 A ES 9202032A ES 2051643 A1 ES2051643 A1 ES 2051643A1
- Authority
- ES
- Spain
- Prior art keywords
- ubidecarenone
- formulations
- oral
- aqueous solutions
- active ingredient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
Pharmaceutical formulations, in the form of aqueous oral solutions, containing ubidecarenone as active ingredient, characterized in that they contain hydrogenated polyethoxylated castor oil 40, as a non-ionic surfactant.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES09202032A ES2051643B1 (en) | 1992-10-13 | 1992-10-13 | ORAL FORMULATIONS OF UBIDECARENONE IN THE FORM OF AQUEOUS SOLUTIONS. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES09202032A ES2051643B1 (en) | 1992-10-13 | 1992-10-13 | ORAL FORMULATIONS OF UBIDECARENONE IN THE FORM OF AQUEOUS SOLUTIONS. |
Publications (2)
Publication Number | Publication Date |
---|---|
ES2051643A1 true ES2051643A1 (en) | 1994-06-16 |
ES2051643B1 ES2051643B1 (en) | 1995-02-16 |
Family
ID=8278404
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES09202032A Expired - Lifetime ES2051643B1 (en) | 1992-10-13 | 1992-10-13 | ORAL FORMULATIONS OF UBIDECARENONE IN THE FORM OF AQUEOUS SOLUTIONS. |
Country Status (1)
Country | Link |
---|---|
ES (1) | ES2051643B1 (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1334961A (en) * | 1961-03-06 | 1963-08-16 | Merck & Co Inc | Stable aqueous solutions based on substituted benzoquinone |
EP0083108A2 (en) * | 1981-12-28 | 1983-07-06 | Eisai Co., Ltd. | Aqueous solution containing ubidecarenone |
ES8600931A1 (en) * | 1983-07-25 | 1985-10-16 | Eisai Co Ltd | Aqueous solution containing lipid-soluble pharmaceutical substance and a process for preparing the same. |
GB2184355A (en) * | 1985-12-24 | 1987-06-24 | Seuref Ag | Ubiquinone pharmaceutical compositions |
EP0325244A1 (en) * | 1988-01-22 | 1989-07-26 | Eisai Co., Ltd. | Aqueous solution of fat-soluble substance |
EP0522433A1 (en) * | 1991-07-11 | 1993-01-13 | Inverni Della Beffa S.P.A. | Oral aqueous solutions containing ubidecarenone |
-
1992
- 1992-10-13 ES ES09202032A patent/ES2051643B1/en not_active Expired - Lifetime
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1334961A (en) * | 1961-03-06 | 1963-08-16 | Merck & Co Inc | Stable aqueous solutions based on substituted benzoquinone |
EP0083108A2 (en) * | 1981-12-28 | 1983-07-06 | Eisai Co., Ltd. | Aqueous solution containing ubidecarenone |
ES8600931A1 (en) * | 1983-07-25 | 1985-10-16 | Eisai Co Ltd | Aqueous solution containing lipid-soluble pharmaceutical substance and a process for preparing the same. |
GB2184355A (en) * | 1985-12-24 | 1987-06-24 | Seuref Ag | Ubiquinone pharmaceutical compositions |
EP0325244A1 (en) * | 1988-01-22 | 1989-07-26 | Eisai Co., Ltd. | Aqueous solution of fat-soluble substance |
EP0522433A1 (en) * | 1991-07-11 | 1993-01-13 | Inverni Della Beffa S.P.A. | Oral aqueous solutions containing ubidecarenone |
Also Published As
Publication number | Publication date |
---|---|
ES2051643B1 (en) | 1995-02-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2688422B1 (en) | ||
CA2181172A1 (en) | Storage-stable prostaglandin compositions | |
GR3023127T3 (en) | Stabilized pharmaceutical compositions containing derivatives of vitamins D2 and D3 | |
FR2671800B1 (en) | OPTICALLY ACTIVE 5H-PYRROLO [3,4-B] PYRAZINE DERIVATIVE, ITS PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING IT. | |
EP0221732A3 (en) | Sustained release tablets | |
TW355683B (en) | Composition containing micronized nebivolol | |
MY118371A (en) | Tetrahydrolipstatin containing compositions | |
IL106562A0 (en) | Pharmaceutical and/or cosmetic compositions and the use thereof | |
TW280774B (en) | ||
IT1263840B (en) | ORAL FORMULATIONS OF UBIDECARENONE IN THE FORM OF CAPSULES | |
NZ511085A (en) | Oral pharmaceutical compositions containing buprenorphin | |
DK0437294T3 (en) | Oral pharmaceutical preparations in unit dosage form | |
AU8332791A (en) | Oral pharmaceutical compositions containing melatonin | |
AU621763B2 (en) | Stable tretinoin emulsified cream formulations | |
IT1250672B (en) | ORAL FORMULATIONS OF UBIDECARENONE IN AQUEOUS SOLUTION | |
IL96903A0 (en) | Topical pharmaceutical compositions comprising a vitamin d3 derivative | |
GB9525598D0 (en) | Pharmaceutical tablet formulations | |
ES2051643A1 (en) | Oral ubidecarenone formulations in the form of aqueous solutions | |
CA2185883A1 (en) | The use of dimeticone as a transport and carrier system and/or drug delivery system | |
HUT61561A (en) | Process for producing octadecyl-/2-(n-methylpiperidino)-ethyl/-phosphate and pharmaceutical compositions comprising same as active ingredient | |
GR1001364B (en) | Ubidecarenone oral formulations in the form of aqueous solutions. | |
DE3261285D1 (en) | Edible pharmaceutical form of a composition of matter containing a fluid dimethyl polysiloxane | |
HK1022278A1 (en) | Pharmaceutical and cosmetic formulations with antimicrobial activity | |
WO1991013606A3 (en) | Use of 3,7-dimethyloctan-1-ol in cosmetic and dermatological preparations | |
GB2161706B (en) | New pharmaceutical and cosmetic compositions containing 10-acetyl-1,8,9-triacetoxyanthracene as active ingredient |